INmune Bio Inc(INMB)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INMB INmune Bio Inc

交易中 11-26 14:01:30 EST

4.85

+0.05

+0.96%

最高4.90	最低4.68	成交量5.96万
今开4.80	昨收4.80	日振幅4.58%
总市值1.07亿	流通市值6,971万	总股本2,217万
成交额28.60万	换手率0.41%	流通股本1,439万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"INMB","market":"US","secType":"STK","nameCN":"INmune Bio Inc","latestPrice":4.846,"timestamp":1732647669700,"preClose":4.8,"halted":0,"volume":59591,"delay":0,"floatShares":14385900,"shares":22172451,"eps":-2.185069,"marketStatus":"交易中","marketStatusCode":2,"change":0.046,"latestTime":"11-26 14:01:30 EST","open":4.8,"high":4.9,"low":4.68,"amount":286016.92044240003,"amplitude":0.045833,"askPrice":4.85,"askSize":104,"bidPrice":4.83,"bidSize":173,"shortable":3,"etf":0,"ttmEps":-2.185069,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732654800000},"adr":0,"listingDate":1549256400000,"adjPreClose":4.8,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":5,"preClose":4.8,"latestTime":"08:28 EST","volume":20,"amount":100,"timestamp":1732627718154},"postHourTrading":{"tag":"盘后","latestPrice":5.2615,"preClose":4.8,"latestTime":"19:52 EST","volume":1540,"amount":7448.15,"timestamp":1732582339338},"volumeRatio":0.470625,"impliedVol":1.9603,"impliedVolPercentile":0.9249},"requestUrl":"/m/hq/s/INMB/tweets","defaultTab":"tweets","newsList":[{"id":"2484414583","title":"Inmune Bio Inc.盘中异动 早盘股价大跌5.10%报4.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484414583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484414583?lang=zh_cn&edition=full","pubTime":"2024-11-20 23:10","pubTimestamp":1732115436,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日23时10分，Inmune Bio Inc.股票出现波动，股价快速跳水5.10%。截至发稿，该股报4.47美元/股，成交量4.5472万股，换手率0.21%，振幅4.35%。Inmune Bio Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Forte Biosciences, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Silexion Therapeutics Corp、Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为1014.91%、434.26%、197.32%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为183.66%、73.14%、65.87%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112023103698e43c25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112023103698e43c25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2484974246","title":"Inmune Bio Inc.盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484974246","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484974246?lang=zh_cn&edition=full","pubTime":"2024-11-20 03:27","pubTimestamp":1732044424,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日03时27分，Inmune Bio Inc.股票出现异动，股价大幅下跌5.13%。截至发稿，该股报4.62美元/股，成交量13.7323万股，换手率0.62%，振幅3.92%。Inmune Bio Inc.股票所在的生物技术行业中，整体跌幅为1.41%。其相关个股中，Syros Pharmaceuticals, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Exicure, Inc.涨幅较大，Syros Pharmaceuticals, Inc.、Tff Pharmaceuticals, Inc.、Exicure, Inc.较为活跃，换手率分别为1217.80%、840.86%、149.55%，振幅较大的相关个股有Syros Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Dogwood Therapeutics, Inc.，振幅分别为91.10%、81.67%、68.54%。Inmune Bio Inc.公司简介：INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120032704971a7818&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120032704971a7818&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2483881428","title":"Inmune Bio Inc.盘中异动 早盘股价大涨5.48%报5.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483881428","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483881428?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:31","pubTimestamp":1731508274,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时31分，Inmune Bio Inc.股票出现异动，股价快速拉升5.48%。截至发稿，该股报5.97美元/股，成交量1184股，换手率0.01%，振幅0.00%。Inmune Bio Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Kairos Pharma, Ltd.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃，换手率分别为323.60%、168.25%、84.06%，振幅较大的相关个股有Entero Therapeutics Inc.、Turnstone Biologics Corp.、Cyclacel Pharmaceuticals, Inc.，振幅分别为8.29%、7.65%、7.63%。Inmune Bio Inc.公司简介：INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223119971a6469&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223119971a6469&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2482422146","title":"Inmune Bio Inc.2024财年第三财季实现净利润-12.09百万美元，同比减少41.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482422146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482422146?lang=zh_cn&edition=full","pubTime":"2024-11-10 00:00","pubTimestamp":1731168049,"startTime":"0","endTime":"0","summary":"11月10日，Inmune Bio Inc.公布财报，公告显示公司2024财年第三财季净利润为-12.09百万美元，同比减少41.24%；其中营业收入为0.00美元，每股基本收益为-0.60美元。从资产负债表来看，Inmune Bio Inc.总负债14.11百万美元，其中短期债务2.63百万美元，资产负债比为3.75，流动比率为2.60。机构评级：截至2024年11月10日，当前有6家机构对Inmune Bio Inc.目标价做出预测，其中目标均价为19.83美元，其中最低目标价为16.00美元，最高目标价为22.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000103abb0ff88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000103abb0ff88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INMB"],"gpt_icon":0},{"id":"2480884857","title":"Inmune Bio Inc.盘中异动 大幅上涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480884857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480884857?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:32","pubTimestamp":1730467975,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时32分，Inmune Bio Inc.股票出现异动，股价大幅上涨5.21%。截至发稿，该股报6.16美元/股，成交量3798股，换手率0.02%，振幅3.08%。Inmune Bio Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Klotho Neurosciences Inc C/Wts 21/06/2029 、Theriva Biologics, Inc.涨幅较大，Theriva Biologics, Inc.、Athira Pharma, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为1286.72%、111.91%、75.01%，振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Mesoblast Ltd、Athira Pharma, Inc.，振幅分别为19.38%、18.08%、12.57%。Inmune Bio Inc.公司简介：INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101213255971a3d6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101213255971a3d6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","INMB","ATHA"],"gpt_icon":1},{"id":"2480014045","title":"INmune 生物公司公布截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2480014045","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480014045?lang=zh_cn&edition=full","pubTime":"2024-11-01 11:32","pubTimestamp":1730431967,"startTime":"0","endTime":"0","summary":"   * INmune Bio Inc   报告，截至9月30日的季度调整后每股亏损60美分，低于去年同期的每股收益-48美分。六位分析师对该季度的平均预期是每股亏损 50 美分。华尔街预期为每股-55美分至-42美分。* INmune Bio Inc 公布的季度每股收益为亏损 60 美分。* 公司报告的季度亏损为 1209 万美元。* INmune Bio Inc 本季度股价上涨了 10.4%，今年迄今为止亏损了 47.2%。华尔街对 INmune 生物公司 12 个月目标价的中位数为 20.50  本摘要由 LSEG 数据于 11 月 1 日 03:32 a.m. UTC 机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"INmune 生物公司公布截至 9 月 30 日的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2479856759","title":"Inmune Bio Inc.盘中异动 下午盘股价大跌5.08%报5.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479856759","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479856759?lang=zh_cn&edition=full","pubTime":"2024-10-31 02:49","pubTimestamp":1730314159,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日02时49分，Inmune Bio Inc.股票出现异动，股价急速下跌5.08%。截至发稿，该股报5.98美元/股，成交量16.6329万股，换手率0.84%，振幅6.98%。Inmune Bio Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Gri Bio, Inc.涨幅较大，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Gri Bio, Inc.较为活跃，换手率分别为5148.05%、3056.48%、375.34%，振幅较大的相关个股有Tharimmune, Inc.、Ensysce Biosciences, Inc.、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为132.02%、77.90%、60.59%。Inmune Bio Inc.公司简介：INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031024920ab85b480&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031024920ab85b480&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2479345268","title":"INmune Bio Inc   预计每股亏损50美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2479345268","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479345268?lang=zh_cn&edition=full","pubTime":"2024-10-30 05:06","pubTimestamp":1730235977,"startTime":"0","endTime":"0","summary":"   * INmune Bio Inc    将于10月31日公布截至2024年9月30日的财报，预计季度收入将出现下降。*    * LSEG的分析师平均预计INmune Bio Inc每股亏损50美分。* 华尔街对 INmune Bio Inc 的 12 个月目标价中位数为 20.50 美元，高于其最新收盘价 6.17 美元。10月29日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"INmune Bio Inc   预计每股亏损50美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INMB"],"gpt_icon":0},{"id":"2479068288","title":"Inmune Bio Inc.盘中异动 股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479068288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479068288?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:45","pubTimestamp":1730209557,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日21时45分，Inmune Bio Inc.股票出现异动，股价快速拉升5.11%。截至发稿，该股报6.48美元/股，成交量4.7536万股，换手率0.24%，振幅3.97%。Inmune Bio Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Glycomimetics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Lixte Biotechnology Holdings, Inc.、Novabay Pharmaceuticals, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为583.33%、275.41%、185.15%，振幅较大的相关个股有Glycomimetics, Inc.、Lixte Biotechnology Holdings, Inc.、Coya Therapeutics, Inc.，振幅分别为54.10%、31.30%、17.17%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029214558ab7f20df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029214558ab7f20df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INMB"],"gpt_icon":1},{"id":"2478754486","title":"Inmune Bio Inc.盘中异动 快速上涨6.27%报5.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478754486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478754486?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:31","pubTimestamp":1730122267,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时31分，Inmune Bio Inc.股票出现波动，股价大幅拉升6.27%。截至发稿，该股报5.76美元/股，成交量3.0774万股，换手率0.16%，振幅0.00%。Inmune Bio Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Monte Rosa Therapeutics, Inc.、Revance Therapeutics, Inc.涨幅较大，Tc Biopharm  Plc、Viracta Therapeutics, Inc.、Immunoprecise Antibodies Ltd.较为活跃，换手率分别为540.99%、47.84%、36.06%，振幅较大的相关个股有Okyo Pharma Ltd Com Npv 、Estrella Immunopharma, Inc.、Genprex, Inc.，振幅分别为9.52%、8.36%、6.56%。Inmune Bio Inc.公司简介：INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821311198e3ecdc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821311198e3ecdc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2476172547","title":"Inmune Bio Inc.盘中异动 股价大跌5.76%报4.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476172547","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476172547?lang=zh_cn&edition=full","pubTime":"2024-10-17 22:50","pubTimestamp":1729176602,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日22时50分，Inmune Bio Inc.股票出现波动，股价大幅下挫5.76%。截至发稿，该股报4.91美元/股，成交量1.7176万股，换手率0.09%，振幅4.99%。Inmune Bio Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Inmune Bio Inc.公司简介：INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017225003a1e16b8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017225003a1e16b8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2475468752","title":"Inmune Bio Inc.盘中异动 快速下跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475468752","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475468752?lang=zh_cn&edition=full","pubTime":"2024-10-15 22:41","pubTimestamp":1729003273,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日22时41分，Inmune Bio Inc.股票出现波动，股价急速跳水5.12%。截至发稿，该股报4.82美元/股，成交量4.9432万股，换手率0.25%，振幅4.63%。Inmune Bio Inc.股票所在的生物技术行业中，整体跌幅为0.36%。Inmune Bio Inc.公司简介：INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101522411398e3c917&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101522411398e3c917&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2470408934","title":"Inmune Bio Inc.盘中异动 早盘股价大涨5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470408934","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470408934?lang=zh_cn&edition=full","pubTime":"2024-09-27 21:35","pubTimestamp":1727444102,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日21时35分，Inmune Bio Inc.股票出现异动，股价大幅拉升5.65%。截至发稿，该股报5.24美元/股，成交量2.996万股，换手率0.15%，振幅2.22%。Inmune Bio Inc.股票所在的生物技术行业中，整体跌幅为0.55%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Onconetix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Onconetix, Inc.、Cardio Diagnostics Holdings Inc.、Seelos Therapeutics, Inc.较为活跃，换手率分别为2158.22%、64.03%、53.18%，振幅较大的相关个股有Tonix Pharmaceuticals Holding Corp.、Chromocell Therapeutics Corporation、Traws Pharma, Inc.，振幅分别为15.96%、15.00%、11.80%。Inmune Bio Inc.公司简介：INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409272135039f1afb2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409272135039f1afb2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2461350088","title":"美国研究综述-阿迪生物科学公司、塔吉特公司、伟世通公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2461350088","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461350088?lang=zh_cn&edition=full","pubTime":"2024-08-22 15:07","pubTimestamp":1724310430,"startTime":"0","endTime":"0","summary":"    路透8月22日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 Aadi Bioscience、Target 和伟世通。要闻              * Aadi Bioscience Inc   ：杰富瑞将其评级从 \"买入 \"下调至 \"持有             * 塔吉特公司  ：杰富瑞将目标价从 190 美元上调至 195 美元             * 伟世通公司   ：加拿大皇家银行将目标价从144美元下调至129美元以下是路透周四报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0985489474.SGD","LU0154245673.USD","PTEN","CHX","AADI","TS","TGT","PDS","LU0878866978.SGD","INMB","SNPS","KLXE","ALC","LU0823411888.USD","HAL","IE0002270589.USD","LU1951198990.SGD","TJX","ALHC","LU0251142724.SGD","DY","LU1988902786.USD","A","SGXZ23171101.USD","OKE","URBN","S","IE00BLSP4239.USD","OIS","COTY","WFRD","WTTR","M","BKR","SLB","ACDC","GTLS","VC","CTRE","WOLF","FTI","RNGR","LU1244550577.SGD","BK4548","LU1951200564.SGD","WHD","TOL"],"gpt_icon":1},{"id":"2461882597","title":"Inmune Bio Inc.盘中异动 快速下挫5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461882597","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461882597?lang=zh_cn&edition=full","pubTime":"2024-08-21 01:03","pubTimestamp":1724173408,"startTime":"0","endTime":"0","summary":"北京时间2024年08月21日01时03分，Inmune Bio Inc.股票出现波动，股价大幅跳水5.29%。截至发稿，该股报6.62美元/股，成交量9.8378万股，换手率0.50%，振幅6.58%。Inmune Bio Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Inmune Bio Inc.公司简介：INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408210103289719959a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408210103289719959a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2459210596","title":"Inmune Bio Inc.盘中异动 急速拉升5.09%报7.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459210596","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459210596?lang=zh_cn&edition=full","pubTime":"2024-08-16 22:05","pubTimestamp":1723817112,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日22时05分，Inmune Bio Inc.股票出现波动，股价快速上涨5.09%。截至发稿，该股报7.22美元/股，成交量2.7429万股，换手率0.14%，振幅4.66%。Inmune Bio Inc.股票所在的生物技术行业中，整体跌幅为0.36%。其相关个股中，Cingulate Inc.、Cingulate Inc C/Wts 10/12/2026 、Seelos Therapeutics, Inc.涨幅较大，Cingulate Inc.、Seelos Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为4130.26%、1500.86%、171.21%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Cingulate Inc.、Seelos Therapeutics, Inc.，振幅分别为100.53%、41.25%、36.81%。Inmune Bio Inc.公司简介：INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081622051397198f72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081622051397198f72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CING","INMB","BK4139","BK4007"],"gpt_icon":1},{"id":"2459100593","title":"Inmune Bio Inc.盘中异动 快速下跌5.01%报6.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459100593","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459100593?lang=zh_cn&edition=full","pubTime":"2024-08-15 00:59","pubTimestamp":1723654761,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日00时59分，Inmune Bio Inc.股票出现波动，股价急速下挫5.01%。截至发稿，该股报6.63美元/股，成交量8.6401万股，换手率0.44%，振幅5.73%。Inmune Bio Inc.股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，Unicycive Therapeutics, Inc.、Zura Bio Limited C/Wts 、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Genprex, Inc.、Conduit Pharmaceuticals Inc.、Tc Biopharm  Plc较为活跃，换手率分别为92.33%、79.15%、70.00%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Genprex, Inc.、Tc Biopharm  Plc，振幅分别为60.83%、58.52%、49.86%。Inmune Bio Inc.公司简介：INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815005921a1d44a66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815005921a1d44a66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2458682382","title":"Inmune Bio Inc.2024财年第二财季实现净利润-9.75百万美元，同比减少50.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458682382","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458682382?lang=zh_cn&edition=full","pubTime":"2024-08-11 00:16","pubTimestamp":1723306564,"startTime":"0","endTime":"0","summary":"8月11日，Inmune Bio Inc.公布财报，公告显示公司2024财年第二财季净利润为-9.75百万美元，同比减少50.00%；其中营业收入为0.00美元，每股基本收益为-0.50美元。从资产负债表来看，Inmune Bio Inc.总负债15.37百万美元，其中短期债务5.11百万美元，资产负债比为3.42，流动比率为2.36。机构评级：截至2024年8月11日，当前有3家机构对Inmune Bio Inc.目标价做出预测，其中目标均价为19.67美元，其中最低目标价为16.00美元，最高目标价为22.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240811001615958e72c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240811001615958e72c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INMB"],"gpt_icon":0},{"id":"2458034988","title":"Inmune Bio Inc.盘中异动 临近午盘股价大涨5.11%报7.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458034988","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458034988?lang=zh_cn&edition=full","pubTime":"2024-08-08 23:52","pubTimestamp":1723132368,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日23时52分，Inmune Bio Inc.股票出现波动，股价大幅拉升5.11%。截至发稿，该股报7.41美元/股，成交量3.6374万股，换手率0.18%，振幅6.38%。Inmune Bio Inc.股票所在的生物技术行业中，整体涨幅为3.09%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Conduit Pharmaceuticals Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Oragenics Inc.较为活跃，换手率分别为378.88%、288.60%、182.73%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Oragenics Inc.、Fibrobiologics, Inc.，振幅分别为103.39%、54.41%、45.58%。Inmune Bio Inc.公司简介：INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808235248aefdf372&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808235248aefdf372&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2457377840","title":"Inmune Bio Inc.盘中异动 早盘股价大跌7.59%报7.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457377840","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457377840?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:38","pubTimestamp":1722865126,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时38分，Inmune Bio Inc.股票出现波动，股价急速下挫7.59%。截至发稿，该股报7.55美元/股，成交量1.025万股，换手率0.05%，振幅1.35%。Inmune Bio Inc.股票所在的生物技术行业中，整体跌幅为1.94%。Inmune Bio Inc.公司简介：INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213846957f3285&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213846957f3285&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INMB","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inmunebio.com","stockEarnings":[{"period":"1week","weight":-0.0144},{"period":"1month","weight":-0.1144},{"period":"3month","weight":-0.3201},{"period":"6month","weight":-0.5026},{"period":"1year","weight":-0.4844},{"period":"ytd","weight":-0.5737}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"INmune Bio Inc.最初于2015年9月25日在内华达州成立。公司的目标是开发和商业化他们的产品，治疗先天免疫系统无法正常工作或者由此导致的疾病。这些疾病包括癌症，其中NK细胞缺少活性导致肿瘤能逃避免疫系统，MDSC增殖以保护肿瘤免受患者免疫系统的攻击，也包括类似功能障碍或其他神经和代谢疾病的引起的慢性感染，慢性炎症引起免疫系统功能障碍进而导致的代谢疾病。INmune Bio Inc.最初的重点是治疗癌症 - 血液系统恶性肿瘤和实体瘤。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.062369},{"month":2,"riseRate":0.2,"avgChangeRate":-0.052369},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.147192},{"month":4,"riseRate":0.666667,"avgChangeRate":0.149477},{"month":5,"riseRate":0.5,"avgChangeRate":-0.001076},{"month":6,"riseRate":0.5,"avgChangeRate":0.096729},{"month":7,"riseRate":0.333333,"avgChangeRate":0.156708},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.04324},{"month":9,"riseRate":0,"avgChangeRate":-0.132961},{"month":10,"riseRate":0.5,"avgChangeRate":-0.013151},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.016796},{"month":12,"riseRate":0.6,"avgChangeRate":0.200435}],"exchange":"NASDAQ","name":"INmune Bio Inc","nameEN":"INmune Bio Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"INmune Bio Inc(INMB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供INmune Bio Inc(INMB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"INmune Bio Inc,INMB,INmune Bio Inc股票,INmune Bio Inc股票老虎,INmune Bio Inc股票老虎国际,INmune Bio Inc行情,INmune Bio Inc股票行情,INmune Bio Inc股价,INmune Bio Inc股市,INmune Bio Inc股票价格,INmune Bio Inc股票交易,INmune Bio Inc股票购买,INmune Bio Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"INmune Bio Inc(INMB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供INmune Bio Inc(INMB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况